414 related articles for article (PubMed ID: 19186948)
1. Identification of S100A8 and S100A9 as serological markers for colorectal cancer.
Kim HJ; Kang HJ; Lee H; Lee ST; Yu MH; Kim H; Lee C
J Proteome Res; 2009 Mar; 8(3):1368-79. PubMed ID: 19186948
[TBL] [Abstract][Full Text] [Related]
2. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
Ang CW; Nedjadi T; Sheikh AA; Tweedle EM; Tonack S; Honap S; Jenkins RE; Park BK; Schwarte-Waldhoff I; Khattak I; Azadeh B; Dodson A; Kalirai H; Neoptolemos JP; Rooney PS; Costello E
Carcinogenesis; 2010 Sep; 31(9):1541-51. PubMed ID: 20622003
[TBL] [Abstract][Full Text] [Related]
3. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
Hermani A; Hess J; De Servi B; Medunjanin S; Grobholz R; Trojan L; Angel P; Mayer D
Clin Cancer Res; 2005 Jul; 11(14):5146-52. PubMed ID: 16033829
[TBL] [Abstract][Full Text] [Related]
4. S100A8, S100A9, and the S100A8/A9 complex in circulating blood are not associated with prostate cancer risk-A re-evaluation study.
Ludwig S; Stephan C; Lein M; Loening SA; Jung K
Prostate; 2007 Sep; 67(12):1301-7. PubMed ID: 17626245
[TBL] [Abstract][Full Text] [Related]
5. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
6. The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: the S100A9 and S100A8 positive cells underlie and invade tumor mass.
Stulík J; Osterreicher J; Koupilová K; Knízek ; Macela A; Bures J; Jandík P; Langr F; Dedic K; Jungblut PR
Electrophoresis; 1999; 20(4-5):1047-54. PubMed ID: 10344284
[TBL] [Abstract][Full Text] [Related]
7. Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer.
Roessler M; Rollinger W; Palme S; Hagmann ML; Berndt P; Engel AM; Schneidinger B; Pfeffer M; Andres H; Karl J; Bodenmüller H; Rüschoff J; Henkel T; Rohr G; Rossol S; Rösch W; Langen H; Zolg W; Tacke M
Clin Cancer Res; 2005 Sep; 11(18):6550-7. PubMed ID: 16166432
[TBL] [Abstract][Full Text] [Related]
8. S100A8 and S100A9 in inflammation and cancer.
Gebhardt C; Németh J; Angel P; Hess J
Biochem Pharmacol; 2006 Nov; 72(11):1622-31. PubMed ID: 16846592
[TBL] [Abstract][Full Text] [Related]
9. Expression of surfactant protein-C, S100A8, S100A9, and B cell markers in renal allografts: investigation of the prognostic value.
Eikmans M; Roos-van Groningen MC; Sijpkens YW; Ehrchen J; Roth J; Baelde HJ; Bajema IM; de Fijter JW; de Heer E; Bruijn JA
J Am Soc Nephrol; 2005 Dec; 16(12):3771-86. PubMed ID: 16251238
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis.
Benoit S; Toksoy A; Ahlmann M; Schmidt M; Sunderkötter C; Foell D; Pasparakis M; Roth J; Goebeler M
Br J Dermatol; 2006 Jul; 155(1):62-6. PubMed ID: 16792753
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of S100A8 and S100A9 protein in bronchial epithelial cells by lipopolysaccharide.
Henke MO; Renner A; Rubin BK; Gyves JI; Lorenz E; Koo JS
Exp Lung Res; 2006 Sep; 32(8):331-47. PubMed ID: 17090475
[TBL] [Abstract][Full Text] [Related]
12. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.
Ehrchen JM; Sunderkötter C; Foell D; Vogl T; Roth J
J Leukoc Biol; 2009 Sep; 86(3):557-66. PubMed ID: 19451397
[TBL] [Abstract][Full Text] [Related]
13. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
14. S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway.
Duan L; Wu R; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zuo G; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
PLoS One; 2013; 8(4):e62092. PubMed ID: 23637971
[TBL] [Abstract][Full Text] [Related]
15. Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagogin.
Xing X; Lai M; Gartner W; Xu E; Huang Q; Li H; Chen G
Proteomics; 2006 May; 6(9):2916-23. PubMed ID: 16586428
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of S100A8 and S100A9 expression in gastric cancer].
Hu Y; Fan B; Zhang LH; Cheng XJ; Niu ZJ; Ji JF
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3369-74. PubMed ID: 24418034
[TBL] [Abstract][Full Text] [Related]
17. Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity.
Leukert N; Vogl T; Strupat K; Reichelt R; Sorg C; Roth J
J Mol Biol; 2006 Jun; 359(4):961-72. PubMed ID: 16690079
[TBL] [Abstract][Full Text] [Related]
18. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis.
Wu W; Juan WC; Liang CR; Yeoh KG; So J; Chung MC
Proteomics Clin Appl; 2012 Apr; 6(3-4):152-62. PubMed ID: 22532451
[TBL] [Abstract][Full Text] [Related]
19. The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins.
Korndörfer IP; Brueckner F; Skerra A
J Mol Biol; 2007 Jul; 370(5):887-98. PubMed ID: 17553524
[TBL] [Abstract][Full Text] [Related]
20. The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment.
Kim JH; Oh SH; Kim EJ; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
Biochem Biophys Res Commun; 2012 Jun; 423(1):60-6. PubMed ID: 22634002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
